Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS. Lee JS, et al. Nat Med. 2006 Apr;12(4):410-6. doi: 10.1038/nm1377. Epub 2006 Mar 12. Nat Med. 2006. PMID: 16532004
Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice.
Factor VM, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen JB, Conner EA, Thorgeirsson SS. Factor VM, et al. Among authors: kaposi novak p. PLoS One. 2010 Sep 16;5(9):e12739. doi: 10.1371/journal.pone.0012739. PLoS One. 2010. PMID: 20862286 Free PMC article.
Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
Kaposi-Novak P, Libbrecht L, Woo HG, Lee YH, Sears NC, Coulouarn C, Conner EA, Factor VM, Roskams T, Thorgeirsson SS. Kaposi-Novak P, et al. Cancer Res. 2009 Apr 1;69(7):2775-82. doi: 10.1158/0008-5472.CAN-08-3357. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276364 Free PMC article.
Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Coulouarn C, Gomez-Quiroz LE, Lee JS, Kaposi-Novak P, Conner EA, Goldina TA, Onishchenko GE, Factor VM, Thorgeirsson SS. Coulouarn C, et al. Hepatology. 2006 Oct;44(4):1003-11. doi: 10.1002/hep.21293. Hepatology. 2006. PMID: 17006931
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.
Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Kaposi-Novak P, et al. J Clin Invest. 2006 Jun;116(6):1582-95. doi: 10.1172/JCI27236. Epub 2006 May 18. J Clin Invest. 2006. PMID: 16710476 Free PMC article.
Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.
Marquardt JU, Seo D, Gómez-Quiroz LE, Uchida K, Gillen MC, Kitade M, Kaposi-Novak P, Conner EA, Factor VM, Thorgeirsson SS. Marquardt JU, et al. Among authors: kaposi novak p. Biochim Biophys Acta. 2012 Jun;1822(6):942-51. doi: 10.1016/j.bbadis.2012.02.012. Epub 2012 Feb 22. Biochim Biophys Acta. 2012. PMID: 22386877 Free PMC article.
Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
Takami T, Kaposi-Novak P, Uchida K, Gomez-Quiroz LE, Conner EA, Factor VM, Thorgeirsson SS. Takami T, et al. Among authors: kaposi novak p. Cancer Res. 2007 Oct 15;67(20):9844-51. doi: 10.1158/0008-5472.CAN-07-1905. Cancer Res. 2007. PMID: 17942915 Free article.
Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis.
Gómez-Quiroz LE, Factor VM, Kaposi-Novak P, Coulouarn C, Conner EA, Thorgeirsson SS. Gómez-Quiroz LE, et al. Among authors: kaposi novak p. J Biol Chem. 2008 May 23;283(21):14581-9. doi: 10.1074/jbc.M707733200. Epub 2008 Mar 18. J Biol Chem. 2008. PMID: 18348981 Free PMC article.
[Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P. Kaposi-Novák P. Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9. Magy Onkol. 2009. PMID: 19318328 Free article. Hungarian.
22 results
Jump to page